We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The FDA has awarded researchers at the University at Buffalo (UB) an $880,000 grant to help accelerate the development of generic equivalents of contraceptives and other drugs delivered vaginally or to the uterus.